Article Versions Notes

Al Ageeli E, Abdulhakim JA, Hussein MH, Alnoman MM, Alkhalil SS, Issa PP, Nemr NA, Abdelmaksoud A, Alenizi DA, Fawzy MS, et al. The HCV-Melanoma Paradox: First Multi-Cohort and Molecular Net-Work Analysis Reveals Lower Incidence but Worse Outcomes—Integrating Clinical, Real-World, and In Silico Data. Medicina. 2024; 60(9):1531. https://doi.org/10.3390/medicina60091531

Al Ageeli, Essam, Jawaher A. Abdulhakim, Mohammad H. Hussein, Maryam M. Alnoman, Samia S. Alkhalil, Peter P. Issa, Nader A. Nemr, Ahmed Abdelmaksoud, Dhaifallah A. Alenizi, Manal S. Fawzy, and et al. 2024. "The HCV-Melanoma Paradox: First Multi-Cohort and Molecular Net-Work Analysis Reveals Lower Incidence but Worse Outcomes—Integrating Clinical, Real-World, and In Silico Data" Medicina 60, no. 9: 1531. https://doi.org/10.3390/medicina60091531

Al Ageeli, E., Abdulhakim, J. A., Hussein, M. H., Alnoman, M. M., Alkhalil, S. S., Issa, P. P., Nemr, N. A., Abdelmaksoud, A., Alenizi, D. A., Fawzy, M. S., & Toraih, E. A. (2024). The HCV-Melanoma Paradox: First Multi-Cohort and Molecular Net-Work Analysis Reveals Lower Incidence but Worse Outcomes—Integrating Clinical, Real-World, and In Silico Data. Medicina, 60(9), 1531. https://doi.org/10.3390/medicina60091531